InvestorsHub Logo
Followers 8
Posts 2073
Boards Moderated 0
Alias Born 04/23/2018

Re: bow-tie post# 26042

Wednesday, 10/20/2021 12:05:15 AM

Wednesday, October 20, 2021 12:05:15 AM

Post# of 27659
Immuno-oncology biotech IO Biotech files for a $100M IPO

*plans to enroll for a Phase 3 trial in combination with pembrolizumab.

IO Biotech filed confidentially on June 3, 2021.

Nasdaq symbol is IOBT.

https://awesomecapital.blogspot.com/2021/10/immuno-oncology-biotech-io-biotech.html

Let's see how the road show goes.

MYMX is IOBT's exploratory partner for any new reader's.

Merck also involved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News